PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsCV Sciences
CV Sciences
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
BosulifBosutinib monohydrate2012-09-042024-2034
Bcr-abl positive chronic myelogenous leukemia
,
Myeloid leukemia
ChantixVarenicline2006-05-102035
Tobacco use cessation
InlytaAxitinib2012-01-272025-2037
Renal cell carcinoma
PristiqDesvenlafaxine2008-02-292027
Major depressive disorder
RapamuneSirolimus1999-09-152029-2040
Kidney transplantation,
Graft rejection
ToriselTemsirolimus2007-05-302026-2032
Renal cell carcinoma,
Mantle-cell lymphoma
TygacilTigecycline2005-06-152026-2033
Bacterial infections,
Intraabdominal infections,
Bacterial skin diseases,
Escherichia coli infections,
Soft tissue infections,
Clostridium infections,
Streptococcal infections,
Bacterial pneumonia,
Staphylococcal infections,
Bacteremia,
Klebsiella infections,
Haemophilus infections,
Legionellosis,
Bacteroides infections,
Infectious skin diseases
VfendVoriconazole2002-05-24
Mycoses,
Candidiasis,
Aspergillosis,
Fusariosis,
Bacterial infections and mycoses
XalkoriCrizotinib2011-08-262025-2029
Non-small-cell lung carcinoma
XeljanzTofacitinib2012-11-062023-2034
Rheumatoid arthritis
1
2
>
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use